During insulin resistance, it has been hypothesized that the vasculoprotective PI3K/Akt/eNOS pathway is impaired in endothelial cells (ECs), whereas the mitogenic MAPK pathway remains intact in vascular SMCs (‘selective insulin resistance’) [15]. The gene discussed is NOS3; the disease is Insulin resistance.